Our Positions

06.05.2019 | Sanna Lauslahti, Managing Director, PIF

New legislation on secondary use of health and social data may attract new investments

The recently adopted Act on the secondary use of health and social data provides a significant leap forward for the Finnish health research environment. This is Pharma Industry Finland PIF’s conviction.